Family-based Telemedicine Vs. Inpatient Anorexia Nervosa Treatment (FIAT)

Last updated: February 11, 2025
Sponsor: Charite University, Berlin, Germany
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anorexia

Vomiting

Treatment

Inpatient multimodal therapy

Family based treatment

Clinical Study ID

NCT06759402
EA2/114/24
  • Ages 8-17
  • All Genders

Study Summary

The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)

  • inpatient treatment indication according to S3 guideline

  • weight < 3. BMI-percentile or

  • weight <10. percentile and psychiatric comorbidity/rapid weight loss/lack of weightgain during outpatient treatment over last three month

  • planned inpatient treatment

  • insured with one of the participating health insurance companies

  • stable internet connection

Exclusion

Exclusion Criteria:

  • weight <67%mBMI

  • acute self harm or danger to others

  • acute psychosis or suicidal tendencies

  • current substance abuse

  • child abuse or domestic violence in the family

  • insured with other health insurance company

  • judicial placement order for inpatient treatment

  • known, currently existing child protection problems or proceedings by the familycourt

Study Design

Total Participants: 200
Treatment Group(s): 2
Primary Treatment: Inpatient multimodal therapy
Phase:
Study Start date:
January 31, 2025
Estimated Completion Date:
December 31, 2027

Connect with a study center

  • Charité- Universitätsmedizin Berlin

    Berlin, 13353
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.